Kawasaki, Japan

Yuka Kanayama


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal2 out of 1,929 
 
Ajinomoto Co., Ltd.
 patents
silverMedal1 out of 2 
 
Kazuo Sugamura
 patents
bronzeMedal1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuka Kanayama: Innovator in Immunology

Introduction

Yuka Kanayama is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of immunology, particularly through her innovative work on interleukin-2 receptor polypeptides. With a total of 2 patents, her research has the potential to impact medical treatments for various diseases.

Latest Patents

Yuka Kanayama's latest patents include a polypeptide that specifically binds to the gamma-chain of the human interleukin-2 receptor. This polypeptide selectively inhibits the binding of the gamma-chain to the beta-chain of the same receptor. The invention has the capability to block the human interleukin-2 response, making it a valuable tool in immunosuppressant therapies. Additionally, her patents describe a method for producing this polypeptide, which can be used to prevent graft rejection after transplantation and to treat inflammatory diseases, including allergic and autoimmune disorders.

Career Highlights

Throughout her career, Yuka Kanayama has worked with notable companies such as Ajinomoto Co., Ltd. and Kazuo Sugamura. Her experience in these organizations has contributed to her expertise in the field of immunology and biotechnology.

Collaborations

Yuka has collaborated with esteemed colleagues, including Toshiro Shimamura and Junji Hamuro. These partnerships have further enriched her research and development efforts.

Conclusion

Yuka Kanayama's innovative work in the field of immunology, particularly her patents related to interleukin-2 receptor polypeptides, showcases her significant contributions to medical science. Her research holds promise for advancing treatments for various diseases and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…